Antimicrobial Resistance Surveillance Market to Grow at a CAGR of 5.88% to 2029

Increasing Public-Private Partnerships and Collaborations and supportive Stringent Regulatory Standard are the drivers for the Global Antimicrobial Resistance Surveillance Market during the forecast period 2025-2029

According to TechSci Research report, “Antimicrobial Resistance Surveillance Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, Global Antimicrobial Resistance Surveillance Market was valued at USD 5.97 billion in 2023 & will see an impressive growth in the forecast period at a CAGR of 5.88% through 2029. The increasing prevalence of antimicrobial resistance (AMR) serves as a significant catalyst for the antimicrobial resistance surveillance market. AMR poses a critical public health threat by diminishing the efficacy of antibiotics and other antimicrobial treatments. As awareness of AMR and its potential ramifications continues to rise, there is a heightened demand for surveillance systems capable of monitoring and tracking resistance patterns, thereby propelling the need for antimicrobial resistance surveillance solutions.

Governments worldwide are proactively addressing the issue of AMR by implementing diverse initiatives and regulatory measures. These efforts aim to bolster surveillance capabilities, advocate for responsible antibiotic usage, and devise strategies to curb the spread of AMR. The supportive stance of governments and the establishment of regulatory frameworks create an enabling environment conducive to the expansion of the antimicrobial resistance surveillance market.

There is an increasing awareness among healthcare professionals about the importance of antimicrobial stewardship and surveillance. Healthcare providers are recognizing the need for effective surveillance systems to guide appropriate antibiotic use, prevent the spread of AMR, and improve patient outcomes. This awareness drives the demand for antimicrobial resistance surveillance solutions in healthcare settings.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Anti    microbial Resistance Surveillance Market”

The One Health approach acknowledges the interdependency of human, animal, and environmental health concerning antimicrobial resistance. There is a growing recognition that addressing AMR necessitates a collaborative and comprehensive strategy spanning various sectors. Consequently, there is an upward trajectory towards integrated surveillance systems that monitor antimicrobial resistance across humans, animals, and the environment. This approach is anticipated to propel the expansion of the antimicrobial resistance surveillance market.

Governments and international entities are establishing surveillance networks to monitor and trace antimicrobial resistance on a broader scale. These networks facilitate the exchange of data, standardization of surveillance methodologies, and concerted efforts to combat AMR. The deployment of national and international surveillance networks is expected to stimulate the demand for antimicrobial resistance surveillance solutions to bolster these endeavors. 

One of the main hurdles lies in the constrained pipeline of new antibiotics under development. Pharmaceutical firms encounter a myriad of scientific, regulatory, and economic obstacles when endeavoring to bring new antibiotics to market, potentially impeding the availability of innovative treatment alternatives for drug-resistant infections. The regulatory pathways governing the approval of new antibiotics are often protracted, costly, and uncertain. Regulatory bodies necessitate extensive clinical evidence substantiating safety, efficacy, and superiority vis-à-vis existing treatments, prolonging the development timeline and deterring investment in antibiotic research and development. Economic challenges, such as narrow profit margins, exorbitant development expenditures, and market volatilities, further deter investment in new antibiotic research. Many pharmaceutical enterprises prioritize investments in chronic disease therapies with superior profit prospects over antibiotics with restricted market size and profitability.

The Global Antimicrobial Resistance Surveillance Market is segmented into Solution, Application, End User, regional distribution, and company.

Based on its Application, The Public Health Surveillance segment is projected to experience rapid growth in the Global Antimicrobial Resistance Surveillance Market during the forecast period. There is growing recognition of the urgent need for robust surveillance systems to monitor and address antimicrobial resistance (AMR) on a global scale. Public health surveillance plays a critical role in tracking resistance patterns, identifying emerging threats, and guiding policy decisions aimed at mitigating the spread of drug-resistant pathogens. Governments and international organizations are prioritizing investments in public health surveillance infrastructure to combat AMR. Many countries have launched national action plans and initiatives to strengthen surveillance capabilities, enhance data collection and analysis, and implement evidence-based interventions to address AMR. The establishment of collaborative networks and partnerships between public health agencies, research institutions, industry stakeholders, and international organizations has facilitated the development and implementation of integrated surveillance strategies for AMR. These partnerships promote information sharing, capacity building, and coordination of surveillance efforts across borders. Efforts to integrate data systems and interoperable platforms have improved the efficiency and effectiveness of public health surveillance for AMR. Integrated surveillance systems enable seamless data sharing and analysis across different levels of the healthcare system, facilitating early detection of resistance trends and timely interventions. Public health surveillance programs often play a central role in antimicrobial stewardship initiatives aimed at promoting judicious antibiotic use, reducing inappropriate prescribing practices, and preventing the emergence and spread of drug resistance. Surveillance data provides valuable insights into prescribing patterns, resistance trends, and the impact of interventions on AMR.

Based on region, North America holds a dominant position in the market, spearheading collaborative endeavors and forging public-private partnerships to tackle challenges in antimicrobial resistance surveillance. These partnerships involve governmental bodies, healthcare institutions, industry players, and academic researchers collaborating to devise innovative solutions and strategies for surveillance and control. The region has embraced technological advancements in antimicrobial resistance surveillance early on, including next-generation sequencing, molecular diagnostics, and data analytics. These cutting-edge technologies enhance surveillance efforts by boosting speed, accuracy, and scalability, enabling real-time monitoring and analysis of resistance patterns.

Major companies operating in Global Antimicrobial Resistance Surveillance Market are:

• Luminex Corporation (DiaSorin)
• Thermo Fisher Scientific Inc
• Accelerate Diagnostics, Inc.
• Liofilchem S.r.I.
• Becton, Dickinson, and Company
• Biomerieux Inc.
• Bruker Corp.
• Danaher Corporation
• Merck KgaA
• Abbott Laboratories Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Antimicrobial Resistance Surveillance Market is characterized by a growing recognition of the urgent need to address the global threat of antimicrobial resistance (AMR). As the incidence of drug-resistant infections continues to rise worldwide, antimicrobial resistance surveillance plays a crucial role in monitoring resistance patterns, guiding treatment decisions, and informing public health interventions to combat AMR effectively”, said Mr. Karan Chechi Research Director of TechSci Research, a research-based management consulting firm.

“Antimicrobial Resistance Surveillance Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Other Applications), By End User (Hospitals & Clinics, Research & Academic Institutes, Others), By Region, and By Competition, 2019-2029F”, has evaluated the future growth potential of Global Antimicrobial Resistance Surveillance Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Antimicrobial Resistance Surveillance Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com